Skip to content

Iridex Corp

IRIX· NasdaqCore metricsCIK 1006045

Electromedical & electrotherapeutic apparatus30 peers

Last sale
Nov 11, 2026 · -4.74%
Market cap
$11.79M
17.56M shares
Filings
1,019
$12.57M
Q2 2026+8.2% FY26 yoy
-$1.27M
Q2 2026N/M FY26 yoy
-$1.03M
Q2 2026N/M FY26 yoy
-$1.31M
Q2 2026derivedN/M FY26 yoy
-$0.07
Q2 2026N/M FY26 yoy
$4.68M
Q2 2026+152.5% FY25 yoy
$11.79M
—
0.2×
3.2×
-16.96%
—

Twelve months to Jul 4, 2026 · derived

Price

$0.671537.82%$0.4085past year
Nov 11, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$52.68MFY 2026
$56.97M0FY 2014FY 2019FY 2026
PeriodEndedValueKindSource trail
FY 20262026-01-03$52,675,000reported
FY 20242024-12-28$48,669,000reported
FY 20232023-12-30$51,869,000reported
FY 20222022-12-31$56,972,000reported
FY 20212022-01-01$53,903,000reported
FY 20202021-01-02$36,347,000reported
FY 20192019-12-28$43,447,000reported
FY 20182018-12-29$42,600,000reported
FY 20172017-12-30$41,593,000reported
FY 20162016-12-31$46,158,000reported
FY 20152016-01-02$41,757,000reported
FY 20142015-01-03$42,814,000reported

Capital returns

Dividends and buybacks · FY2009 to FY2016
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2016—$59.00K$59.00K—11.52M sh+14.6%—
FY2015—$1.56M$1.56M—10.05M sh+2.0%—
FY2014—$4.67M$4.67M—9.86M sh−1.4%135.4%
FY2013—$426.00K$426.00K—9.99M sh+16.8%110.1%
FY2012—$2.84M$2.84M—8.55M sh−4.3%—

Segments

Revenue by Geography, FY2020 to FY2026FY2020United States · FY2020 · $19.31MAsia/Pacific Rim · FY2020 · $7.06MAmericas, excluding the U.S. · FY2020 · $1.97MEurope · FY2020 · $8.01MFY2021United States · FY2021 · $25.56MAsia/Pacific Rim · FY2021 · $12.23MAmericas, excluding the U.S. · FY2021 · $2.54MEurope · FY2021 · $13.57MFY2022United States · FY2022 · $29.18MEurope, Middle East and Africa · FY2022 · $13.80MAsia/Pacific Rim · FY2022 · $10.93MAmericas, excluding the U.S. · FY2022 · $3.06MFY2023United States · FY2023 · $26.05MEurope, Middle East and Africa · FY2023 · $13.52MAsia/Pacific Rim · FY2023 · $10.23MAmericas, excluding the U.S. · FY2023 · $2.06MFY2024United States · FY2024 · $22.69MEurope, Middle East and Africa · FY2024 · $11.82MAsia/Pacific Rim · FY2024 · $11.95MAmericas, excluding the U.S. · FY2024 · $2.21MFY2025United States · FY2025 · $22.69MEurope, Middle East and Africa · FY2025 · $11.82MAsia/Pacific Rim · FY2025 · $11.95MAmericas, excluding the U.S. · FY2025 · $2.21MFY2026United States · FY2026 · $23.21MEurope, Middle East and Africa · FY2026 · $14.39MAsia/Pacific Rim · FY2026 · $12.95MAmericas, excluding the U.S. · FY2026 · $2.12M
LineFY2026ShareChange
United States$23.21M44%+2.3%
Europe, Middle East and Africa$14.39M27%+21.7%
Asia/Pacific Rim$12.95M25%+8.4%
Americas, excluding the U.S.$2.12M4.0%−3.8%
Europe———
Total$52.68M

From the 10-K filed Apr 2, 2026IRIX

Electromedical & electrotherapeutic apparatus

Iridex Corp is the 13th largest of the 31 covered companies the SEC files under this code, by revenue. SIC 3845

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Iridex Corp · CIK 1006045 · Engraved from SEC EDGAR